Article metrics

Download PDFPDF
Extended Report
A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2014 to March 2021

AbstractFullPdf
Jan 2014106456167
Feb 20142403549
Mar 20141141939
Apr 2014722324
May 2014681720
Jun 2014512612
Jul 2014591510
Aug 201442710
Sep 201442711
Oct 201446913
Nov 2014481011
Dec 2014531322
Jan 2015401817
Feb 20152679
Mar 2015461315
Apr 2015126536133
May 20155132962
Jun 20151972135
Jul 20151241419
Aug 2015813120
Sep 20151252123
Oct 201596915
Nov 20151152931
Dec 2015111612
Jan 2016981113
Feb 2016731116
Mar 201660119
Apr 201675711
May 20167369
Jun 20166335
Jul 20165087
Aug 2016601114
Sep 2016671119
Oct 20165524
Nov 201665912
Dec 20163589
Jan 2017401010
Feb 20176596
Mar 2017581718
Apr 20171221612
May 2017552015
Jun 2017701311
Jul 20171061210
Aug 201715537
Sep 201711175
Oct 201712885
Nov 2017136115
Dec 20176964
Jan 201891107
Feb 201811895
Mar 2018156136
Apr 2018128145
May 20188462
Jun 20189186
Jul 201810274
Aug 201866148
Sep 20187994
Oct 20187264
Nov 20181191513
Dec 20186774
Jan 2019611910
Feb 20194586
Mar 20196484
Apr 20197365
May 20195854
Jun 20192063
Jul 20196963
Aug 20197642
Sep 20195721
Oct 20196363
Nov 2019791112
Dec 20195853
Jan 20207952
Feb 20204453
Mar 20208374
Apr 20205975
May 20204982
Jun 20204721
Jul 20203933
Aug 20204696
Sep 20209256
Oct 20204032
Nov 20203630
Dec 20206520
Jan 20215921
Feb 20217445
Mar 202172103
Total93079801182